Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | DCC-2812 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on DCC-2812, a putative GCN2 activator (Sep 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| DCC-2812 | DCC 2812|DCC2812 | Limited information is currently available on DCC-2812, a putative GCN2 activator (Sep 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06966024 | Phase I | DCC-2812 | Study of DCC-2812 in Participants With Advanced Genitourinary Cancers | Recruiting | USA | 0 |